Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma (2024)
- Authors:
- Autor USP: PEREIRA, JULIANA - FM
- Unidade: FM
- DOI: 10.1007/s40487-024-00282-7
- Subjects: ESTUDOS RETROSPECTIVOS; LINFOMA; ANTINEOPLÁSICOS
- Agências de fomento:
- Language: Inglês
- Objetivos de Desenvolvimento Sustentável (ODS):
03. Saúde e bem-estar
- Imprenta:
- Source:
- Título: Oncology and Therapy
- ISSN: 2366-1070
- Volume/Número/Paginação/Ano: v. 12, n. 3, p. 585-598, 2024
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
DELAMAIN, Marcia Torresan et al. Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma. Oncology and Therapy, v. 12, n. 3, p. 585-598, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79464. Acesso em: 21 jan. 2026. -
APA
Delamain, M. T., Cardoso, A. C. F., Pericole, F. V., Araujo, S. S. da S., Fogliatto, L., Higashi, M., et al. (2024). Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma. Oncology and Therapy, 12( 3), 585-598. doi:10.1007/s40487-024-00282-7 -
NLM
Delamain MT, Cardoso ACF, Pericole FV, Araujo SS da S, Fogliatto L, Higashi M, Pereira J, Silva RL da, Werutsky G, Radtke P de PG. Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma [Internet]. Oncology and Therapy. 2024 ; 12( 3): 585-598.[citado 2026 jan. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79464 -
Vancouver
Delamain MT, Cardoso ACF, Pericole FV, Araujo SS da S, Fogliatto L, Higashi M, Pereira J, Silva RL da, Werutsky G, Radtke P de PG. Long-term safety and effectiveness of Rituximab biosimilar RTXM83: a retrospective extension study in brazilian patients with diffuse large B-Cell lymphoma [Internet]. Oncology and Therapy. 2024 ; 12( 3): 585-598.[citado 2026 jan. 21 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79464 - Expression of CysLTR1 and 2 in Maturating Lymphocytes of Hyperplasic Tonsils Compared to Peripheral Cells in Children
- Association between quality of response and outcomes in patients with newly diagnosed mantle cell lymphoma receiving VR-CAP versus R-CHOP in the phase 3 LYM-3002 study
- A difficult case of angioimmunoblastic T-cell lymphoma to diagnose
- Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study
- Clinical prognostic models in diffuse large B cell lymphoma patients are still essencial in the rituximab era
- Factors associated with survival in patients with lymphoma and HIV
- Follicular lymphoma: refining prognostic models and impact of pod-24 in clinical outcomes
- Time-to-treatment of diffuse large B-cell lymphoma in São Paulo
- GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
- Comparison of Subcutaneous Versus Intravenous Administration of Rituximab As Maintenance Treatment for Follicular Lymphoma: Results From a Two-Stage, Phase IB Study
Informações sobre o DOI: 10.1007/s40487-024-00282-7 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
